KIRKUS REVIEWS (starred review)
One of the world's most renowned and forward-thinking oncologists recounts 35 years of cancer research and tells us why we should be optimistic about the future. [more]

PUBLISHERS WEEKLY (starred review) 
DeVita, an oncologist and professor at Yale School of Medicine, collaborates with his daughter DeVita-Raeburn on this engaging, informative, and inspiring history of DeVita’s prominent role in developing innovative cancer treatments. [more]

LIBRARY JOURNAL (starred review)
DeVita (medical oncology & epidemiology, Yale Univ.) is a pioneer in the development of chemotherapy and one of the biggest names in oncology. This title, cowritten with the author’s daughter DeVita-Raeburn (The Empty Room), a journalist who covers science, health, and society, is a lively personal history of cancer treatment sprinkled with biography, patients’ stories, politics, doctors behaving badly, and plenty of unvarnished opinion. [more]

THE CHICAGO TRIBUNE
A few scenes from "The Death of Cancer" would slot nicely into an episode of "House of Cards," the Netflix series about Washington dirty dealings. A powerful senator sidles up to his soon-to-be ex-wife at a public gathering. His approach attracts press photographers, as he no doubt knew it would. But while he talks to his wife, he holds a piece of paper and looks directly at the man sitting beside her. The senator is Ted Kennedy (D-Mass.). [more]

THE NEW YORK TIMES
Eliminate Excessive Government Regulation
and Oversight of Cancer Program

Additional resources are sorely needed in the fight against cancer — but no moonshot will be successful unless the current program is given the flexibility to act more efficiently and quickly. [more]

THE NEW YORK TIMES
Science and Politics Collide in ‘The Death of Cancer’
The scene is a wild cocktail party in Washington at the tail end of the Kennedy administration. Our innocent young narrator, new to the rituals of power, watches in fascination as one of his superiors dances by with a half-undressed woman slung over a shoulder. By the end of the evening, he has helped hoist another of his bosses, dead drunk, out of a bathtub. [more]

THE NEW YORKER
Tough Medicine. A disturbing report from the front lines of the war on cancer.
In the fall of 1963, not long after Vincent T. DeVita, Jr., joined the National Cancer Institute as a clinical associate, he and his wife were invited to a co-worker’s party. At the door, one of the institute’s most brilliant researchers, Emil Freireich, presented them with overflowing Martinis. [more]

THE NEW YORK POST
We could win the War on Cancer — if only the government would let us
Forty-four years ago, President Richard Nixon declared a War on Cancer. Most people don’t realize it, but we’ve already won it, says Dr. Vincent DeVita. [more]

THE CANCER LETTER
DeVita's History of Oncology Told with Candor and Optimism
“The Emperor of All Maladies” was a history of oncology, and a good one. “The Death of Cancer” is a memoir of one of the greats of medical oncology. It is a history from someone who was there, making history. [more]

THE WALL STREET JOURNAL
Hidden Combat in the Cancer War. Bruising battles not only with tumor cells but with hide-bound institutions and bureaucracies.
In the war on cancer, Vincent DeVita is a battle-tested veteran, a pioneer in oncology who opened the door to many of the promising treatments coming out of labs today. [more]

NPR/Terri Gross
Oncologist Discusses Advancements In Treatment And The Ongoing War On Cancer
"This is FRESH AIR. I'm Terry Gross. My guest, Dr. Vincent DeVita, is a pioneer in the field of oncology and the author of the new book, "The Death Of Cancer." [more]

MANAGED CARE
A Conversation with Vincent DeVita, MD: No Truce Sought in Cancer War: ‘We Want to Cure This Disease’
Vincent DeVita, MD, was director of the National Cancer Institute and the National Cancer Program from 1980 to 1988 and director of the Yale Cancer Center from 1993 to 2003. His new book, titled The Death of Cancer and cowritten with his daughter, Elizabeth DeVita-Raeburn, came out late last year. [more]